Expression of methotrexate transporters and metabolizing enzymes in rheumatoid synovial tissue

Journal of Rheumatology

Volumn 40, Issue 9, 2013, Pages 1519-1522

  Stamp, Lisa K ^a   Hazlett, Jody ^b   Highton, John ^b   Hessian, Paul A ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Genes; Methotrexate; Rheumatoid arthritis; Synovium

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; FOLYLPOLYGLUTAMATE SYNTHASE; GAMMA GLUTAMYL HYDROLASE; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN 1; REDUCED FOLATE CARRIER; SALAZOSULFAPYRIDINE; THYMIDYLATE SYNTHASE; TUMOR NECROSIS FACTOR INHIBITOR;

ABCB1 GENE; ABCC1 GENE; ABCG2 GENE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG MECHANISM; DRUG METABOLISM; DRUG TRANSPORT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FPGS GENE; GENE EXPRESSION; GGH GENE; HUMAN; HUMAN TISSUE; MALE; MTR GENE; MTRR GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SLC19A1 GENE; SYNOVIUM; TYMS GENE;

GENES; METHOTREXATE; RHEUMATOID ARTHRITIS; SYNOVIUM;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ATP-BINDING CASSETTE TRANSPORTERS; FEMALE; FERREDOXIN-NADP REDUCTASE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; REDUCED FOLATE CARRIER PROTEIN; SYNOVIAL MEMBRANE; THYMIDYLATE SYNTHASE;

EID: 84883431581     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.130066     Document Type: Article

References (12)

1. Stamp L, Hazlett J, Roberts R, Frampton C, Highton J, Hessian P. Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action. Arthritis Res Ther 2012;14:R138.
2. Arnett F, Edworthy SM, Bloch D, McShane D, Fries J, Cooper N, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
3. Nakashima-Matsushita N, Homma T, Yu S, Matsuda T, Sunahara N, Nakamura T, et al. Selective expression of folate receptor beta and its possible role in methotrexate transport in synovial macrophages from patients with rheumatoid arthritis. Arthritis Rheum 1999;42:1609-16. (Pubitemid 30263627)
4. Van der Heijden JW, Oerlemans R, Tak PP, Assaraf YG, Kraan MC, Scheffer GL, et al. Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide. Arthritis Rheum 2009;60:669-77.
5. Hider S, Owen A, Hartkoorn R, Khoo S, Back D, Silman AJ, et al. Down regulation of multidrug resistance protein-1 expression in patients with early rheumatoid arthritis exposed to methotrexate as a first disease-modifying antirheumatic drug. Ann Rheum Dis 2006;65:1390-3. (Pubitemid 44620452)
6. McCloskey DE, McGuire JJ, Russell CA, Rowan BG, Bertino JR, Pizzorno G, et al. Decreased folylpolyglutamate synthetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sublines. J Biol Chem 1991;266:6181-7. (Pubitemid 21906201)
7. Stranzl T, Wolf J, Leeb BF, Smolen JS, Pirker R, Filipits M. Expression of folylpolyglutamyl synthetase predicts poor response to methotrexate therapy in patients with rheumatoid arthritis. Clin Exp Rheumatol 2003;21:27-32. (Pubitemid 36267528)
8. Angelis-Stoforidis P, Vajda FJ, Christophidis N. Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis. Clin Exp Rheumatol 1999;17:313-20. (Pubitemid 29265678)
9. Stamp LK, O'Donnell JL, Chapman PT, Zhang M, James J, Frampton C, et al. Methotrexate polyglutamate concentrations are not associated with disease control in rheumatoid arthritis patients on longterm MTX therapy. Arthritis Rheum 2010;62:359-68.
10. Dervieux T, Furst D, Lein DO, Capps R, Smith K, Caldwell J, et al. Pharmacogenetic and metabolite measurements are associated with clinical status in rheumatoid arthritis patients treated with methotrexate: results of a multicentered cross sectional observational study. Ann Rheum Dis 2005;64:1180-5. (Pubitemid 41113353)
11. Lemos C, Kathmann I, Giovannetti E, Beliën J, Scheffer G, Calhau C, et al. Cellular folate status modulates the expression of BCRP and MRP multidrug transporters in cancer cell lines from different origins. Mol Cancer Ther 2009;8:655-64.
12. Hashizume M, Yoshida H, Tanaka K, Suzuki M, Matsumoto I, Sumida T, et al. Interleukin-6 regulates anti-arthritis effect of methotrexate via reduction of SLC19A1 expression in a mouse arthritis model. Arthritis Res Ther 2012;14:R96.